Completed PHASE1 INTERVENTIONAL 3-arm NCT00705926

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection

Sponsor: Massachusetts General Hospital

Interventions Highly Active Antiretroviral Therapy (HAART) No treatment

Updated 7 times since 2017 Last updated: Aug 30, 2017 Started: Oct 31, 2008 Primary completion: Feb 7, 2013 Completion: Jul 16, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00705926, this PHASE1 trial focuses on HIV Infections and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 7 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Sep 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Feb 2017 — Sep 2017 [monthly]

Unknown Status PHASE1
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States